Volume 14, Number 7—July 2008
Invasive Amebiasis in Men Who Have Sex with Men, Australia
Highlight and copy the desired format.
|EID||Stark D, van Hal SJ, Matthews G, Harkness J, Marriott D. Invasive Amebiasis in Men Who Have Sex with Men, Australia. Emerg Infect Dis. 2008;14(7):1141-1143. https://dx.doi.org/10.3201/eid1407.080017|
|AMA||Stark D, van Hal SJ, Matthews G, et al. Invasive Amebiasis in Men Who Have Sex with Men, Australia. Emerging Infectious Diseases. 2008;14(7):1141-1143. doi:10.3201/eid1407.080017.|
|APA||Stark, D., van Hal, S. J., Matthews, G., Harkness, J., & Marriott, D. (2008). Invasive Amebiasis in Men Who Have Sex with Men, Australia. Emerging Infectious Diseases, 14(7), 1141-1143. https://dx.doi.org/10.3201/eid1407.080017.|
Entamoeba histolytica is a pathogenic ameba that has recently been recognized as an emerging pathogen in men who have sex with men (MSM) in Asia-Pacific countries where it is not endemic, i.e., Japan, Taiwan, and Republic of Korea. We report locally acquired invasive amebiasis in Sydney, Australia, exclusively in MSM.
Entamoeba histolytica is a pathogenic ameba that can cause invasive intestinal and extra-intestinal disease. The most frequent manifestations of invasive amebiasis are colitis and liver abscesses (1). Although E. histolytica is one of the most common parasitic infections worldwide, invasive disease remains uncommon in industrialized counties. Recent studies from Japan, Taiwan, and Republic of Korea, areas where E. histolytica endemicity is generally low, suggest that amebiasis is an emerging parasitic infection that occurs exclusively in men who have sex with men (MSM) (2–6). In Australia, the documented incidence of Entamoeba spp. in the general population is 1%–4% (1). In MSM, the rates of Entamoeba spp. carriage were previously documented to be as high as 37% (7). However, these studies failed to differentiate the pathogenic E. histolytica from the morphologically identical nonpathogenic E. moshkovskii and E. dispar, therefore leaving the accuracy of these results in question. A study in Australia that used molecular methods showed E. histolytica prevalence rates in MSM to be as low as 0.1% (8). Impaired host immunity is associated with increased pathogenicity of invasive amebiasis. Recent studies indicate an increased risk for invasive amebiasis among persons with HIV (9,10). We report 5 cases of invasive amebiasis in MSM from Sydney, New South Wales, Australia, from December 2006 through October 2007.
Of the 5 patients, 3 had amebic colitis and 2 had amebic liver abscesses, all were MSM, 4 were HIV-infected, mean age was 45 years (range 35–57 years), and median CD4 count was 713 cells/mm3 (Table). No associations among any of the patients were noted. All patients were receiving highly active antiretroviral therapy at the time of examination. Of the 5 patients, 4 had not traveled extensively in the past 4 years, but the remaining patient had traveled to Malaysia and China 6 months before onset of colitis. Other possible risk factors for acquisition were identified in 4 patients: 3 had had high-risk sex behavior at sex-on-premises venues, and the other had had a male partner who had traveled to countries where invasive amebiasis was highly endemic.
The patients had bloody diarrhea and abdominal pain for 2–4 weeks. Routine fecal cultures were negative for bacterial pathogens. Microscopic examination of permanently fixed, stained fecal smears was positive for E. histolytica/dispar/moshkovskii complex. Diagnosis of E. histolytica was confirmed by PCR targeting the small subunit ribosomal DNA as described (8). Results of serologic examination of these patients were positive; all titers were >256 according to indirect hemagglutination antibody assay, which confirmed invasive disease. However, although antibodies against amebae indicate invasive disease, these antibodies can also be seen in persons with asymptomatic colonization with amebae (1).
The 2 patients with liver abscesses each had large, solitary abscesses in the right lobe of the liver (8 × 6 × 6 cm and 7.5 × 6.2 × 6.6 cm). In 1 patient, the abscess ruptured through the liver capsule, and collapse of the right middle and lower lung lobes and a resultant pleural effusion complicated the subphrenic collection of pus from the abscess. Levels of liver enzymes (alkaline phosphatase and gamma glutamyl transferase), C-reactive protein, and neutrophils (absolute numbers) were raised. Both patients underwent percutaneous drainage of their liver abscess; cultures of aspirated pus were negative for bacteria and fungi. Results of indirect hemagglutination antibody assay were positive; titer was >256. Microscopy and PCR of fecal samples were negative for E. histolytica. For these 2 patients with amebic liver abscess, the diagnosis was delayed; they had had symptoms for >2 weeks and were then treated for bacterial liver abscess before the correct diagnosis was made.
All 5 patients made a successful recovery after treatment with metronidazole. In addition, all were treated for cyst carriage with paromomycin, a luminal amebicide.
E. histolytica carriage and invasive disease are common in the Asia-Pacific region, especially in developing countries. In countries where E. histolytica prevalence is low, such as Japan, Taiwan, Republic of Korea, and Australia, rates of amebiasis are low and invasive amebiasis is uncommon. Recent reports from a number of these countries, however, suggest that invasive amebiasis is emerging as an increasingly common infection, specifically in the MSM population (2–6). MSM have a higher risk than others for intestinal parasite carriage; not only are they substantially more likely to harbor intestinal protozoa, but they are also more likely to harbor multiple parasites (11). These protozoa are transmitted by the fecal–oral route; high rates of oral–anal sex by MSM are considered the reason for increased rates of carriage. Because E. histolytica is also transmitted by the fecal–oral route, MSM may also have an increased risk for E. histolytica carriage. This higher rate of asymptomatic carriage is likely to translate into a greater risk for invasive disease. Recent seroprevalence studies in Taiwan that used indirect hemagglutination antibody assay have confirmed MSM’s statistically significant higher risk for E. histolytica exposure (5).
In Japan, amebiasis has become endemic in MSM; symptomatic E. histolytica infection occurs almost exclusively in middle-aged MSM in the large cities of Japan (2,3). Similar findings are reported for MSM in Taiwan (4,5). More recently, a study from the Republic of Korea documented invasive amebiasis (amebic liver abscess) in HIV-infected MSM (6). To date, the emergence of E. histolytica infections in MSM seems to be limited to the Asia-Pacific region. In a large retrospective study of 34,000 HIV-infected patients in United States, only 2 patients had invasive amebiasis (12). The reasons for this geographic variation are unclear, but it is likely linked to the higher background prevalence of E. histolytica infections in Asia. Regional E. histolytica strains show a high degree of diversity but no major differences between regional genotypes; other factors relating to host or virulence factors may be important but are as yet undetermined (3). We now report local acquisition of E. histolytica by MSM in Australia; as shown by the above 5 cases of invasive disease and 3 previous cases of noninvasive infections also acquired locally (13).
Of note, 4 of the 5 patients we report were HIV infected. Seroprevalence rates of E. histolytica (determined by indirect hemagglutination antibody assay) are higher for HIV-infected persons then for HIV-nonninfected persons, although the reasons are unclear (5,14). Higher rates of E. histolytica carriage in MSM likely reflect high-risk sex behavior and multiple exposures, resulting in increased risk for acquisition. This hypothesis is supported by the high rates of sexually transmitted infections that occur in Australian MSM who visit sex-on-premises venues (15). Antibody responses predominantly occur with invasive disease. Whether immunosuppression caused by HIV infection attenuates the risk for invasive amebiasis is unknown. Historically, the evidence has been contradictory, and most published studies had had severe limitations. Nevertheless, more recent data seem to indicate that HIV-infected persons are at increased risk for invasive amebiasis (9,10).
The emergence of E. histolytica in MSM is of public health concern because it has the potential to become endemic in this population in Australia and to cause severe disease. Further study is needed to identify the reasons for the geographic variation and the role of E. histolytica in invasive disease. In conclusion, invasive amebiasis has the potential to emerge as an important parasitic infection in the Asia-Pacific region, especially in HIV-infected MSM in countries where E. histolytica is not endemic.
Dr Stark is a senior hospital scientist at St. Vincent’s Hospital, Darlinghurst. His research interests are directed at molecular diagnosis of parasitic diseases.
- van Hal SJ, Stark DJ, Fotedar R, Marriott D, Ellis JT, Harkness JL. Amoebiasis: current status in Australia. Med J Aust. 2007;186:412–6.
- Ohnishi K, Murata M. Present characteristics of symptomatic amebiasis due to Entamoeba histolytica in the east-southeast area of Tokyo. Epidemiol Infect. 1997;119:363–7.
- Ohnishi K, Kato Y, Imamura A, Fukayama M, Tsunoda T, Sakaue Y, Present characteristics of symptomatic Entamoeba histolytica infection in the big cities of Japan. Epidemiol Infect. 2004;132:57–60.
- Hung CC, Deng HY, Hsiao WH, Hsieh SM, Hsiao CF, Chen MY, Invasive amebiasis as an emerging parasitic disease in patients with human immunodeficiency virus type 1 infection in Taiwan. Arch Intern Med. 2005;165:409–15.
- Tsai JJ, Sun HY, Ke LY, Tsai KS, Chang SY, Hsieh SM, Higher seroprevalence of Entamoeba histolytica infection is associated with human immunodeficiency virus type 1 infection in Taiwan. Am J Trop Med Hyg. 2006;74:1016–9.
- Park WB, Choe PG, Jo JH, Kim SH, Bang JH, Kim HB, Amebic liver abscess in HIV-infected patients, Republic of Korea. Emerg Infect Dis. 2007;13:516–7.
- Law CL, Walker J, Qassim MH. Factors associated with the detection of Entamoeba histolytica in homosexual men. Int J STD AIDS. 1991;2:346–50.
- Fotedar R, Stark D, Beebe N, Marriott D, Ellis J, Harkness J. PCR detection of Entamoeba histolytica, Entamoeba dispar, and Entamoeba moshkovskii in stool samples from Sydney, Australia. J Clin Microbiol. 2007;45:1035–7.
- Seeto RK, Rockey DC. Amebic liver abscess: epidemiology, clinical features, and outcome. West J Med. 1999;170:104–9.
- Hung CC, Ji DD, Sun HY, Lee YT, Hsu SY, Chang SY, Increased risk for Entamoeba histolytica infection and invasive amebiasis in HIV-seropositive men who have sex with men in Taiwan. PLoS Negl Trop Dis. 2008;2:e175.
- Stark D, Fotedar R, van Hal S, Beebe N, Marriott D, Ellis JT, Prevalence of enteric protozoa in human immunodeficiency virus (HIV)–positive and HIV-negative men who have sex with men from Sydney, Australia. Am J Trop Med Hyg. 2007;76:549–52.
- Lowther SA, Dworkin MS, Hanson DL. Entamoeba histolytica/Entamoeba dispar infections in human immunodeficiency virus–-infected patients in the United States. Clin Infect Dis. 2000;30:955–9.
- Stark DJ, Fotedar R, Ellis JT, Harkness JL. Locally acquired infection with Entamoeba histolytica in men who have sex with men in Australia. Med J Aust. 2006;185:417.
- Ko NY, Lee HC, Chang JL, Lee NY, Chang CM, Lee MP, Prevalence of human immunodeficiency virus and sexually transmitted infections and risky sexual behaviors among men visiting gay bathhouses in Taiwan. Sex Transm Dis. 2006;33:467–73.
- O’Sullivan B, Delpech V, Pontivivo G, Karagiannis T, Marriott D, Harkness J, Shigellosis linked to sex venues, Australia. Emerg Infect Dis. 2002;8:862–4.
- Table. Summary of clinical characteristics of 5 patients with invasive amebiasis, Australia, December 2006–October 2007
Please use the form below to submit correspondence to the authors or contact them at the following address:
Damien Stark, Division of Microbiology, SydPath, St. Vincent’s Hospital, Darlinghurst 2010, NSW, Australia;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 12, 2010
- Page last updated: July 12, 2010
- Page last reviewed: July 12, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)